Is Preimplantation Genetic Testing Associated with Increased Risk of Abnormal Placentation After Frozen Embryo Transfer?

Abstract

Objective This study aimed to assess the association of preimplantation genetic testing (PGT) with abnormal placentation among a cohort of pregnancies conceived after frozen embryo transfer (FET).

Study Design This is a retrospective cohort study of women who conceived via FET at the University of California, San Francisco from 2012 to 2016 with resultant delivery at the same institution. The primary outcome was abnormal placentation, including placenta accreta, retained placenta, abruption, placenta previa, vasa previa, marginal or velamentous cord insertion, circumvallate placenta, circummarginate placenta, placenta membranacea, bipartite placenta, and placenta succenturiata. Diagnosis was confirmed by reviewing imaging, delivery, and pathology reports. Our secondary outcome was hypertensive disease of pregnancy.

Results A total of 311 pregnancies were included in analysis; 158 (50.8%) underwent PGT. Baseline demographic characteristics were similar between groups except for age at conception and infertility diagnosis. Women with PGT were more likely to undergo single embryo transfer (82.3 vs. 64.1%, p < 0.001). There were no statistically significant differences in the rate of the primary outcome (26.6 vs. 27.4%, p = 0.86) or hypertensive disorders of pregnancy (33.5 vs. 33.3%, p = 0.97), which remained true after multivariate analysis was performed.

Conclusion Among pregnancies conceived after FET, PGT is not associated with a statistically significant increased risk of abnormal placentation or hypertensive disorders of pregnancy.

Key Points

• In pregnancies conceived by FET, PGT is not associated with increased risk of abnormal placentation.

• In pregnancies conceived by FET, PGT is not associated with increased risk of hypertensive disorders.

• Differences in outcomes of PGT pregnancies may be related to FET rather than trophectoderm biopsy.

Keywords

abnormal placentation - frozen embryo transfer - in vitro fertilization - preimplantation genetic testing

Note

This study was presented at the Society of Maternal-Fetal Medicine Annual Meeting, February 3–8, 2020, Grapevine, TX.

Publication History

Received: 06 May 2020

Accepted: 22 June 2020

Article published online:
31 July 2020

• References

• 1 Chen M, Wei S, Hu J, Quan S. Can comprehensive chromosome screening technology improve IVF/ICSI outcomes? A comprehensive meta-analysis. PLoS One 2015; 10 (10) e0140779
• 2 Centers for Disease Control and Prevention. American Society for Reproductive Medicine, Society for Assisted Reproductive Technology National Summary Report. Atlanta, GA: US Department of Health and Human Services; 2017
• 3 LaBonte ML. An analysis of US fertility centre educational materials suggests that informed consent for preimplantation genetic diagnosis may be inadequate. J Med Ethics 2012; 38 (08) 479-484
• 4 Vermey BG, Buchanan A, Chambers GM. et al. Are singleton pregnancies after assisted reproduction technology (ART) associated with a higher risk of placental anomalies compared with non-ART singleton pregnancies? A systemic review and meta-analysis. BJOG 2019; 126 (02) 209-218
• 5 Sacha CR, Harris AL, James K. et al. Placenta pathology in live births conceived with in vitro fertilization after fresh and frozen embryo transfer. Am J Obstet Gynecol 2020; 222 (04) 360.e1-360.e16
• 6 Roque M, Valle M, Sampaio M, Geber S. Obstetric outcomes after fresh versus frozen-thawed embryo transfers: a systematic review and meta-analysis. JBRA Assist Reprod 2018; 22 (03) 253-260
• 7 Bay B, Ingerslev HJ, Lemmen JG, Degn B, Rasmussen IA, Kesmodel US. Preimplantation genetic diagnosis: a national multicenter obstetric and neonatal follow-up study. Fertil Steril 2016; 106 (06) 1363-1369.e1
• 8 Zhang WY, von Versen-Höynck F, Kapphahn KI, Fleischmann RR, Zhao Q, Baker VL. Maternal and neonatal outcomes associated with trophectoderm biopsy. Fertil Steril 2019; 112 (02) 283-290.e2